Harnessing the pyrroloquinoxaline scaffold for FAAH and MAGL interaction: definition of the structural determinants for enzyme inhibition
作者:Margherita Brindisi、Simone Brogi、Samuele Maramai、Alessandro Grillo、Giuseppe Borrelli、Stefania Butini、Ettore Novellino、Marco Allarà、Alessia Ligresti、Giuseppe Campiani、Vincenzo Di Marzo、Sandra Gemma
DOI:10.1039/c6ra12524g
日期:——
carboxamides/carbamates supported on a pharmacogenic pyrroloquinoxaline scaffold as inhibitors of the endocannabinoid catabolizing enzymes fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL). Structure–activity relationships and molecular modelling studies allowed the definition of the structural requirements for dual FAAH/MAGL inhibition and led to the identification of a small set of derivatives
本文描述了在药源性吡咯并喹喔啉骨架上负载的哌嗪和4-氨基哌啶羧酰胺/氨基甲酸酯作为内源性大麻素分解酶脂肪酸酰胺水解酶(FAAH)和单酰基甘油脂肪酶(MAGL)的抑制剂的开发。结构-活性关系和分子建模研究允许双重FAAH / MAGL抑制的结构要求的定义,并导致鉴定出一小部分衍生物(化合物5e,i,k,m)对两种酶均表现出平衡的抑制谱,与化合物5m作为子集的领跑者。有利的计算理化性质建议进一步研究特定的类似物。